Tocilizumab

Arthritis drug tocilizumab can help critically-ill Covid patients recover, trial finds

by

The arthritis drug tocilizumab can help critically-ill Covid-19 patients recover, a large British trial has found. Patients given the drug in a clinical trial led by Imperial College London were found to be 87 per cent more likely to see their symptoms improve within 28 days than patients not given the drug. But because the … Read more

Coronavirus: Tocilizumab doesn’t work on infection, say studies

by

Tocilizumab doesn’t keep Covid-19 patients alive, researchers have claimed in a blow to the goal of discovering more treatments. Hopes were rising that the drug, originally designed for rheumatoid arthritis, would save lives by halting the immune system ‘storm’ that has killed thousands of infected patients. But doctors in New Jersey have now said there … Read more